1. Home
  2. EIG vs TVTX Comparison

EIG vs TVTX Comparison

Compare EIG & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIG
  • TVTX
  • Stock Information
  • Founded
  • EIG 2000
  • TVTX 2008
  • Country
  • EIG United States
  • TVTX United States
  • Employees
  • EIG N/A
  • TVTX N/A
  • Industry
  • EIG Property-Casualty Insurers
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EIG Finance
  • TVTX Health Care
  • Exchange
  • EIG Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • EIG 1.2B
  • TVTX 1.4B
  • IPO Year
  • EIG 2007
  • TVTX N/A
  • Fundamental
  • Price
  • EIG $46.53
  • TVTX $14.31
  • Analyst Decision
  • EIG Strong Buy
  • TVTX Strong Buy
  • Analyst Count
  • EIG 1
  • TVTX 15
  • Target Price
  • EIG $58.00
  • TVTX $33.57
  • AVG Volume (30 Days)
  • EIG 159.8K
  • TVTX 1.6M
  • Earning Date
  • EIG 07-30-2025
  • TVTX 07-31-2025
  • Dividend Yield
  • EIG 2.75%
  • TVTX N/A
  • EPS Growth
  • EIG N/A
  • TVTX N/A
  • EPS
  • EIG 4.13
  • TVTX N/A
  • Revenue
  • EIG $860,200,000.00
  • TVTX $273,533,000.00
  • Revenue This Year
  • EIG N/A
  • TVTX $73.84
  • Revenue Next Year
  • EIG $5.56
  • TVTX $46.72
  • P/E Ratio
  • EIG $11.27
  • TVTX N/A
  • Revenue Growth
  • EIG N/A
  • TVTX 75.65
  • 52 Week Low
  • EIG $41.48
  • TVTX $6.80
  • 52 Week High
  • EIG $54.44
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • EIG 38.15
  • TVTX 38.47
  • Support Level
  • EIG $46.27
  • TVTX $13.88
  • Resistance Level
  • EIG $47.52
  • TVTX $15.04
  • Average True Range (ATR)
  • EIG 0.69
  • TVTX 0.69
  • MACD
  • EIG -0.12
  • TVTX 0.02
  • Stochastic Oscillator
  • EIG 10.16
  • TVTX 24.43

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: